0001104659-19-019720.txt : 20190403 0001104659-19-019720.hdr.sgml : 20190403 20190403173308 ACCESSION NUMBER: 0001104659-19-019720 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190401 FILED AS OF DATE: 20190403 DATE AS OF CHANGE: 20190403 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dhingra Kapil CENTRAL INDEX KEY: 0001456849 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38596 FILM NUMBER: 19730255 MAIL ADDRESS: STREET 1: 39 BLISS AVENUE CITY: TENAFLY STATE: NJ ZIP: 07670 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Replimune Group, Inc. CENTRAL INDEX KEY: 0001737953 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 822082553 STATE OF INCORPORATION: MA FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 18 COMMERCE WAY CITY: WOBURN STATE: MA ZIP: 01801 BUSINESS PHONE: 781-995-2443 MAIL ADDRESS: STREET 1: 18 COMMERCE WAY CITY: WOBURN STATE: MA ZIP: 01801 4 1 a4.xml 4 X0306 4 2019-04-01 0 0001737953 Replimune Group, Inc. REPL 0001456849 Dhingra Kapil 18 COMMERCE WAY WOBURN MA 01801 1 0 0 0 Stock Option (right to buy) 15.50 2019-04-01 4 A 0 13500 0 A 2029-04-01 Common Stock 13500 13500 D The shares underlying this option vest entirely on April 1, 2020. /s/ Robert Coffin, attorney-in-fact 2019-04-03